Originally posted by Chuckytah
View Post
Unconfigured Ad
Collapse
This topic is closed.
X
X
-
Originally posted by eulbra View PostDo you need transcriptoe or only DGE? I think it is cheap if you out sourcing your project with basic analysis and then you can do your own analysis by your self. That will help you to improv yourself. You can ask for raw data for your own analyis.
It is a transcritpomic analysis but i need DGE too.
Comment
-
-
Hello everyone! How are you all doing?
My name is Desiree Wilson. I am a first year graduate student at University of Texas Health Science Center San Antonio. I need to learn how to analyze NGS data and so I am learning R and Rsamtools. I am very grateful for the opportunity to learn so much from you all. I hope that I can be of service in return. ^_^ <3
Comment
-
-
Hello, everyone
I am new to deep sequencing with a background in molecular biology. I have very little computer programming experience.
I am working on a couple of projects that will use NGS technology. The first one I am currently immersed in is a virus discovery project from insect samples. I am currently using Velvet for de novo assembly from 100bp paired end data on that project.
The second project is a re-sequencing of plant virus genome from samples stored in herbaria - specifically looking at viral evolution questions. Does anyone have suggestions on software or experimental design advice?
Nikki
Comment
-
-
New to SeqAnswers, and I could use some help
Hello All:
I am a user in the Carribean area (San Juan, PR). I am currently preparing to transition a project from lots of microarray data to ChIP-Seq, and planning to use Illumina MiSeq for that. I have a lot of microarray data that supports a model of gene function, and ChIP-seq should help to sort out some of those features.
This brings up an issue that has been troubling for some time. It may be more relevant to a microarray users group (and so kindly please redirect me, if necessary). The crux of the problem is annotation; I work on zebrafish, and the microarrays were designed with the ZV7 (current June 2007) version of the genome. There is a group of perhaps 20-40% of the genome that is either poorly annotated, or not at all annotated. The issue is that over the years, many of the genes have been identified, but I'm 'stuck' with the version of the annotations that were current at the time of the release.
My desire is to find and employ any tools that might help to make the annotations somewhat more complete. Does anyone out there have any suggestions?
Much appreciated,
Comment
-
-
Hello all,
I'm exploring NGS options for analysing structural alterations. In general, I'm interested in how to go from DNA sample to data I can understand.
This looks like a good place to start reading, though it's way more complicated a site than any I've used before.
Comment
-
-
Hi everybody
Federico here, PhD student in Mainz (Germany) at the Institute of Molecular Biology.
Quickly, my focus in bioinformatics: ChIP-seq and RNA-seq analysis, currently collaborating in setting up a pipeline for the lab.
Curiously eager to learn in this field, I am sure I will enjoy this community!
Comment
-
-
Hi all
I'm a PhD student working in Oslo, Norway. Just signed up here yesterday and all ready I've had lots of help from this forum. At the moment I'm working on Illumina RNAseq data. Looking forward to exchange ideas, tips and tricks with you all!
Cheers,
Monica
Comment
-
-
Hi
Hi, everyone. My name is Jasmine. I am major in biostatistics and I am new in this new area.
I have a lot of questions ahout the NGS data analysis, especially genotype calling and variation calling. But I don't have any idea at where I start analysing my data. could someone help me with introductionary documents?
Comment
-
-
Hi
Hi all,
My name is Kris and I work at a genomics lab in India. New to this community and NGS. Doing my first big expt after the 5500XL training. Here to share my experiences and to find answers to the problems we will encounter.
Cheers,
Kris
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
21 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
||
|
Started by SEQadmin2, 07-23-2026, 11:41 AM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
07-23-2026, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
26 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
38 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
Comment